Immunome, Inc. (IMNM) vs Zymeworks Inc. (ZYME)
A side-by-side comparison of Immunome, Inc. and Zymeworks Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMNM
Immunome, Inc.
$19.65HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
ZYME
Zymeworks Inc.
$25.63HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — IMNM vs ZYME
growth of $100 · dividends reinvested · last 6yIMNM +57.4% (+7.9%/yr)ZYME -39.5% (-8.0%/yr)IMNM compounded faster over this window
IMNM ZYME
IMNM vs ZYME: by the numbers
- •ZYME is the larger company ($1.89B vs $1.88B market cap).
- •Both run net losses; ZYME's is the smaller (-404.00% vs -3059.99% net margin).
Metrics side by side
Valuation
| Metric | IMNM | ZYME |
|---|---|---|
| Forward P/E | N/A | 24.70 |
| P/S ratio | N/A | 50.78 |
| P/B ratio | 3.58 | 23.46 |
Profitability
| Metric | IMNM | ZYME |
|---|---|---|
| Gross margin | 57.43% | 100.00% |
| Operating margin | -3084.76% | -87.33% |
| Net margin | -3059.99% | -404.00% |
| ROE | -48.43% | -186.63% |
| ROIC | -51.06% | -44.06% |
Growth (annualized)
| Metric | IMNM | ZYME |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.35% |
| Total return CAGR (5Y) | 2.88% | -1.37% |
Frequently asked
- How have IMNM and ZYME total returns compared?
- Over the past 5 years, IMNM delivered 2.88% and ZYME delivered -1.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.